Literature DB >> 11474540

Vagal neurostimulation in patients with coronary artery disease.

A V Zamotrinsky1, B Kondratiev, J W de Jong.   

Abstract

We tested the hypotheses that (1) progression of coronary artery disease (CAD) increases sympathetic inflow to the heart, thus impairing cardiac blood supply, and (2) reduced sympathetic tone improves cardiac microcirculation and ameliorates severity of anginal symptoms. Electrical irritation of the nerve auricularis--a sensitive ramus of the vagus nerve--provides a central sympatholytic action. Using this technique, we studied the effects of vagal neurostimulation (VNS) on hemodynamics, the content of atrial noradrenergic nerves and the microcirculatory bed of CAD patients. VNS was performed in the preoperative period of CAD patients with severe angina pectoris. The comparison groups consisted of untreated patients with CAD or Wolff-Parkinson-White syndrome. Atrial tissue of patients with this syndrome (n = 6); with effort angina (n = 14); with angina at rest (n = 10); and with severe angina treated with VNS (n = 8) contained the following volume percentages of noradrenergic nerves: 1.7+/-0.1%, 1.3+/-0.3%, 0.5+/-0.1% (p < 0.05 vs. the other groups) and 1.3+/-0.2%, respectively. In these groups, cardiac microcirculatory vessels (diameter, 10-20 microm) had the following densities: 2.7+/-0.2%, 3.4+/-0.2%, 2.0+/-0.4% (p < 0.05 vs. the other groups) and 3.3+/-0.3%, respectively. VNS treatment abolished angina at rest, decreased heart rate and blood pressure. It improved left ventricular ejection fraction from 50+/-1.5% to 58+/-1.0% (p < 0.05), also changing left ventricular diastolic filling. The ratio of time velocity integrals of the early (Ei) to late (Ai) waves increased from 1.07+/-0.12 to 1.65+/-0.17 after VNS (p < 0.05). In electrocardiograms of VNS-treated patients, QRS- and QT-duration were shortened. the PQ-interval did not change, but T-wave configuration improved. In the postoperative period, heart failure occurred in 90% of the control group. vs. 12% in patients treated with VNS (p < 0.05). We conclude that CAD is characterized by overactivity of sympathetic cardiac tone. Vagal stimulation reduced sympathetic inflow to the heart, seemingly via an inhibition of norepinephrine release from sympathetic nerves. VNS' sympatholytic/vagotonic action dilated cardiac microcirculatory vessels and improved left ventricular contractility in patients with severe CAD.

Entities:  

Mesh:

Year:  2001        PMID: 11474540     DOI: 10.1016/S1566-0702(01)00227-2

Source DB:  PubMed          Journal:  Auton Neurosci        ISSN: 1566-0702            Impact factor:   3.145


  26 in total

1.  Low-level transcutaneous vagus nerve stimulation attenuates cardiac remodelling in a rat model of heart failure with preserved ejection fraction.

Authors:  Liping Zhou; Adrian Filiberti; Mary Beth Humphrey; Christian D Fleming; Benjamin J Scherlag; Sunny S Po; Stavros Stavrakis
Journal:  Exp Physiol       Date:  2018-11-29       Impact factor: 2.969

2.  Numerical modeling of percutaneous auricular vagus nerve stimulation: a realistic 3D model to evaluate sensitivity of neural activation to electrode position.

Authors:  Amine M Samoudi; Stefan Kampusch; Emmeric Tanghe; Jozsef C Széles; Luc Martens; Eugenijus Kaniusas; Wout Joseph
Journal:  Med Biol Eng Comput       Date:  2017-02-13       Impact factor: 2.602

3.  Muscarinic 2 receptors modulate cardiac proteasome function in a protein kinase G-dependent manner.

Authors:  Mark J Ranek; Curtis K Kost; Chengjun Hu; Douglas S Martin; Xuejun Wang
Journal:  J Mol Cell Cardiol       Date:  2014-02-05       Impact factor: 5.000

4.  Sympathetic nerve fibers in human cervical and thoracic vagus nerves.

Authors:  Atsuko Seki; Hunter R Green; Thomas D Lee; LongSheng Hong; Jian Tan; Harry V Vinters; Peng-Sheng Chen; Michael C Fishbein
Journal:  Heart Rhythm       Date:  2014-04-24       Impact factor: 6.343

5.  Acupoint dependence of depressor and bradycardic responses elicited by manual acupuncture stimulation in humans.

Authors:  Hidehiro Nakahara; Toru Kawada; Shin-Ya Ueda; Eriko Kawai; Hiromi Yamamoto; Masaru Sugimachi; Tadayoshi Miyamoto
Journal:  J Physiol Sci       Date:  2019-11-09       Impact factor: 2.781

Review 6.  Peripheral cardiac sympathetic hyperactivity in cardiovascular disease: role of neuropeptides.

Authors:  Julia Shanks; Neil Herring
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2013-09-04       Impact factor: 3.619

Review 7.  Vagus nerve stimulation: from pre-clinical to clinical application: challenges and future directions.

Authors:  Gaetano M De Ferrari; Peter J Schwartz
Journal:  Heart Fail Rev       Date:  2011-03       Impact factor: 4.214

Review 8.  Cardiac autonomic nerve stimulation in the treatment of heart failure.

Authors:  Mariko Kobayashi; Alex Massiello; Jamshid H Karimov; David R Van Wagoner; Kiyotaka Fukamachi
Journal:  Ann Thorac Surg       Date:  2013-06-05       Impact factor: 4.330

9.  Association of cardiac and vascular changes with ambient PM2.5 in diabetic individuals.

Authors:  Alexandra Schneider; Lucas M Neas; Don W Graff; Margaret C Herbst; Wayne E Cascio; Mike T Schmitt; John B Buse; Annette Peters; Robert B Devlin
Journal:  Part Fibre Toxicol       Date:  2010-06-02       Impact factor: 9.400

10.  Exacerbation of electrical storm subsequent to implantation of a right vagal stimulator.

Authors:  Alaa A Shalaby; Aiman El-Saed; Jan Nemec; John J Moossy; Jeffrey R Balzer
Journal:  Clin Auton Res       Date:  2007-09-26       Impact factor: 4.435

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.